Combined metabolomics and 16S rDNA sequence analyses of the gut microbiome reveal the action mechanism of Fructus Akebiae against hepatic fibrosis
ObjectivesTo explore the mechanism underlying the effect of Fructus Akebiae (FAE) against hepatic fibrosis in mice through combined network pharmacology, liver metabolomics, and 16S rDNA analyses of the gut microbiota.MethodsIn this study, we randomly divided mice into the control, model, FAE high-d...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2024.1492383/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832539891890651136 |
|---|---|
| author | Rong-Rong Wu Duo-Rui Nie Fang-Hui He Zhi-Hang Li Fei Xu Fei Xu Fei Xu |
| author_facet | Rong-Rong Wu Duo-Rui Nie Fang-Hui He Zhi-Hang Li Fei Xu Fei Xu Fei Xu |
| author_sort | Rong-Rong Wu |
| collection | DOAJ |
| description | ObjectivesTo explore the mechanism underlying the effect of Fructus Akebiae (FAE) against hepatic fibrosis in mice through combined network pharmacology, liver metabolomics, and 16S rDNA analyses of the gut microbiota.MethodsIn this study, we randomly divided mice into the control, model, FAE high-dose, FAE medium-dose, and FAE low-dose groups to analyze the pathological changes in the hepatic fibrosis and levels of the α-SMA, collagen 1, Nuclear Factor Kappa B (NF-κ B), Toll Like Receptor 4 (TLR4). The gut microbiota was analyzed through 16S rDNA sequencing analysis of liver metabolites using liquid chromatography-mass spectrometry. Furthermore, network pharmacology was used to determine the specific molecular regulation mechanism of FAE in hepatic fibrosis treatment.ResultsFAE treatment markedly improved the pathological changes in the hepatic fibrosis. Analysis revealed that FAE administration reversed the carbon tetrachloride (CCl4)-induced dysbiosis by increasing the abundance of Akkermansia and reducing that of Cyanobacteria. Additionally, metabolomic analysis showed that FAE treatment reversed the CCl4-induced metabolic disorders by regulating amino and nucleotide sugar metabolism. Furthermore, correlation analysis showed that Akkermansia and Verrucomicobiota were closely related to D-tolasaccharide and maltotetraose saccharide. Moreover, network pharmacology indicated that FAE might regulate the signaling pathway through the JUN/CASP3/NOS3/PTGS2/HSP90AA1 during treatment.ConclusionFAE may be a promising treatment for hepatic fibrosis, and its protective effects are associated with improvements in the microbiome and metabolic disorders. |
| format | Article |
| id | doaj-art-5097765858454c2182fa39d75a331cfb |
| institution | Kabale University |
| issn | 2296-858X |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj-art-5097765858454c2182fa39d75a331cfb2025-02-05T07:32:44ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-02-011110.3389/fmed.2024.14923831492383Combined metabolomics and 16S rDNA sequence analyses of the gut microbiome reveal the action mechanism of Fructus Akebiae against hepatic fibrosisRong-Rong Wu0Duo-Rui Nie1Fang-Hui He2Zhi-Hang Li3Fei Xu4Fei Xu5Fei Xu6School of Pharmacy, Hunan University of Chinese Medicine, Changsha, Hunan, ChinaGraduate School, Hunan University of Chinese Medicine, Changsha, ChinaSchool of Pharmacy, Hunan University of Chinese Medicine, Changsha, Hunan, ChinaSchool of Pharmacy, Hunan University of Chinese Medicine, Changsha, Hunan, ChinaCollege of Pharmacy, Hunan University of Chinese Medicine, Changsha, ChinaHunan Engineering Technology Research Center for Bioactive Substance Discovery of Chinese Medicine, Changsha, ChinaHunan Province Sino-US International Joint Research Center for Therapeutic Drugs of Senile Degenerative Diseases, Changsha, ChinaObjectivesTo explore the mechanism underlying the effect of Fructus Akebiae (FAE) against hepatic fibrosis in mice through combined network pharmacology, liver metabolomics, and 16S rDNA analyses of the gut microbiota.MethodsIn this study, we randomly divided mice into the control, model, FAE high-dose, FAE medium-dose, and FAE low-dose groups to analyze the pathological changes in the hepatic fibrosis and levels of the α-SMA, collagen 1, Nuclear Factor Kappa B (NF-κ B), Toll Like Receptor 4 (TLR4). The gut microbiota was analyzed through 16S rDNA sequencing analysis of liver metabolites using liquid chromatography-mass spectrometry. Furthermore, network pharmacology was used to determine the specific molecular regulation mechanism of FAE in hepatic fibrosis treatment.ResultsFAE treatment markedly improved the pathological changes in the hepatic fibrosis. Analysis revealed that FAE administration reversed the carbon tetrachloride (CCl4)-induced dysbiosis by increasing the abundance of Akkermansia and reducing that of Cyanobacteria. Additionally, metabolomic analysis showed that FAE treatment reversed the CCl4-induced metabolic disorders by regulating amino and nucleotide sugar metabolism. Furthermore, correlation analysis showed that Akkermansia and Verrucomicobiota were closely related to D-tolasaccharide and maltotetraose saccharide. Moreover, network pharmacology indicated that FAE might regulate the signaling pathway through the JUN/CASP3/NOS3/PTGS2/HSP90AA1 during treatment.ConclusionFAE may be a promising treatment for hepatic fibrosis, and its protective effects are associated with improvements in the microbiome and metabolic disorders.https://www.frontiersin.org/articles/10.3389/fmed.2024.1492383/fullFructus Akebiaehepatic fibrosisnetwork pharmacology16s rDNA sequencingAkkermansiaVerrucomicrobiota |
| spellingShingle | Rong-Rong Wu Duo-Rui Nie Fang-Hui He Zhi-Hang Li Fei Xu Fei Xu Fei Xu Combined metabolomics and 16S rDNA sequence analyses of the gut microbiome reveal the action mechanism of Fructus Akebiae against hepatic fibrosis Frontiers in Medicine Fructus Akebiae hepatic fibrosis network pharmacology 16s rDNA sequencing Akkermansia Verrucomicrobiota |
| title | Combined metabolomics and 16S rDNA sequence analyses of the gut microbiome reveal the action mechanism of Fructus Akebiae against hepatic fibrosis |
| title_full | Combined metabolomics and 16S rDNA sequence analyses of the gut microbiome reveal the action mechanism of Fructus Akebiae against hepatic fibrosis |
| title_fullStr | Combined metabolomics and 16S rDNA sequence analyses of the gut microbiome reveal the action mechanism of Fructus Akebiae against hepatic fibrosis |
| title_full_unstemmed | Combined metabolomics and 16S rDNA sequence analyses of the gut microbiome reveal the action mechanism of Fructus Akebiae against hepatic fibrosis |
| title_short | Combined metabolomics and 16S rDNA sequence analyses of the gut microbiome reveal the action mechanism of Fructus Akebiae against hepatic fibrosis |
| title_sort | combined metabolomics and 16s rdna sequence analyses of the gut microbiome reveal the action mechanism of fructus akebiae against hepatic fibrosis |
| topic | Fructus Akebiae hepatic fibrosis network pharmacology 16s rDNA sequencing Akkermansia Verrucomicrobiota |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2024.1492383/full |
| work_keys_str_mv | AT rongrongwu combinedmetabolomicsand16srdnasequenceanalysesofthegutmicrobiomerevealtheactionmechanismoffructusakebiaeagainsthepaticfibrosis AT duoruinie combinedmetabolomicsand16srdnasequenceanalysesofthegutmicrobiomerevealtheactionmechanismoffructusakebiaeagainsthepaticfibrosis AT fanghuihe combinedmetabolomicsand16srdnasequenceanalysesofthegutmicrobiomerevealtheactionmechanismoffructusakebiaeagainsthepaticfibrosis AT zhihangli combinedmetabolomicsand16srdnasequenceanalysesofthegutmicrobiomerevealtheactionmechanismoffructusakebiaeagainsthepaticfibrosis AT feixu combinedmetabolomicsand16srdnasequenceanalysesofthegutmicrobiomerevealtheactionmechanismoffructusakebiaeagainsthepaticfibrosis AT feixu combinedmetabolomicsand16srdnasequenceanalysesofthegutmicrobiomerevealtheactionmechanismoffructusakebiaeagainsthepaticfibrosis AT feixu combinedmetabolomicsand16srdnasequenceanalysesofthegutmicrobiomerevealtheactionmechanismoffructusakebiaeagainsthepaticfibrosis |